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Challenges for Implementing a
PTSD Preventive Genomic
Sequencing Program in the U.S.
Military
Gabriel Lázaro-Muñoz 1 & Eric T. Juengst 23
There is growing interest in using the quickly developing
field of genomics to contribute to military readiness and
effectiveness. Specifically, influential military advisory panels
have recommended that the U.S. military apply genomics to help
treat, prevent, or minimize the risk for post-traumatic stress
disorder (PTSD) among service members. This article highlights
some important scientific, legal, and ethical challenges regarding
the development and deployment of a preventive genomic
sequencing (PGS) program to predict the risk of PTSD among
military service members.
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I. Introduction
Technological superiority is an essential aspect of military
readiness and effectiveness. To achieve this, the United States
Department of Defense (DoD) invests approximately $70 billion each
year in research, development, test, and evaluation programs. 4 These
investments advance technologies that range from precision strike
weapons and unmanned vehicles to environmental quality and
medical technologies. 5 There is growing interest in using the quickly
developing field of genomics to contribute to military readiness and
effectiveness. 6 Specifically, influential military advisory panels have
4.

U.S. DEF. DEP’T, DEPARTMENT OF DEFENSE BUDGET FISCAL 2014:
RESEARCH, DEVELOPMENT, TEST & EVALUATION (RDT&E) PROGRAMS
(R-1)
3
(Apr.
2013),
http://comptroller.defense.gov/Portals/
45/Documents/defbudget/fy2014/fy2014_r1.pdf
[hereinafter
DoD
RDT&E].

5.

Id. at N-5, A-6, N-12, A-3, D-48.

6.

JASON, THE $100 GENOME: IMPLICATIONS FOR THE DOD 1 (2010)
[hereinafter, JASON Report]; PATRICK LIN, MAXWELL J. MEHLMAN &
KEITH ABNEY, ENHANCED WARFIGHTERS: RISK, ETHICS, AND POLICY 2
(2014).
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recommended that the U.S. military apply genomics to help treat,
prevent, or minimize the risk for post-traumatic stress disorder
(PTSD) among service members. 7 This article highlights some
important scientific, legal, and ethical challenges regarding the
development and deployment of a preventive genomic sequencing
(PGS) program to predict the risk of PTSD among military service
members.
The field of genomics examines the informational content and
functional dynamics of the genes that make up the human genome.
An important endeavor in genomics is the identification of genetic
variants indicating that an individual is at an increased risk of
developing a poor health outcome, such as different types of cancer,
heart disease, diabetes, and mental health disorders. Recently, the
development of massively parallel DNA-sequencing technologies
(MPS) has fueled progress in genomics by allowing the sequencing of
numerous genes at a time and decreasing the cost of sequencing an
individual’s genome. 8 MPS has made whole genome- and whole
exome-sequencing (WGS/WES) more accessible to researchers and
clinicians, which is quickly expanding the medical community’s
understanding of the genetics of certain diseases and the potential
applications of genomic technologies to both the civilian and military
contexts.
DoD has long demonstrated an interest in implementing genetic
technologies in the military. To date, DoD has implemented a
successful DNA registry for identifying human remains, and routinely
screens service men and women for genetic conditions such as sickle
cell anemia and Glucose-6-Phosphate Dehydrogenase (G6PD)
deficiency. 9 The recent surge in WGS/WES research has further
increased DoD’s interest in applying genomic technologies to the
7.

See JASON Report, supra note 3, at 43; Million Veteran Program
(MVP), U.S. DEP’T VET. AFF. (Mar. 25, 2015), http://www.research.va.
gov/MVP/.

8.

DNA Sequencing Costs: Data from the NHGRI Genome Sequencing
Program (GSP), NAT’L HUM. GENOME RES. INST. (Oct. 31, 2014),
http://www.genome.gov/sequencingcosts/; E.D. Green & M.S. Guyer.
Charting a Course for Genomic Medicine from Base Pairs to Bedside,
470 NATURE 204, 205 (2011); see Tom Walsh et al., Detection of
inherited mutations for breast and ovarian cancer using genomic
capture and massively parallel sequencing, 107 PROC. NAT’L ACAD. SCIS.
12629, 12629–30 (2010).

9.

Hemoglobin S and Erythrocyte Glucose-6-Phosphate Dehydrogenase
Deficiency Testing Program, DoD Instruction 6465.1 (Jul. 29, 1981);
Susannah Baruch & Kathy Hudson, Civilian and Military Genetics:
Nondiscrimination Policy in a Post-GINA World, 83 AM. J. HUM.
GENETICS 435, 439 (2008); Mark Nunes, GenePOPS—Genes in
Uniform: Don’t Test, Don’t Tell, GENETICS & PUB. POL’Y CTR. (Jan. 10,
2006) http://www.dnapolicy.org/video/genepops/011006/index.htm.
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military context. In 2010, the JASON Defense Advisory Panel
released a report on the opportunities and challenges of WGS/WES
technologies for the military. 10 The JASON report’s major
recommendation was a call to action:
The DoD should establish policies that result in the collection of
genotype and phenotype data, the application of bioinformatics
tools to support the health and effectiveness of military
personnel, and the resolution of ethical and social issues that
arise from these activities. The DoD and the VA should affiliate
with or stand up a genotype/phenotype analysis program that
addresses their respective needs. Waiting even two years to
initiate this process may place them unrecoverably behind in
the race for personal genomics information and applications. 11

PTSD was one of the few phenotypes specifically identified by the
JASON report, which could be of benefit to DoD because it “might
reasonably be expected to have a genetic component [and] have
special relevance to military performance and medical cost
containment.” 12 Nevertheless, the use of PTSD genomics in the
military raises a number of questions that must be addressed to avoid
extemporaneous applications of genomic technologies that do not
sufficiently maximize the benefits and minimize the harms of using
these technologies. 13
An examination of the challenges of implementing a PTSD-PGS
program in the military was beyond the scope of the JASON report.
This article aims to examine some of the important issues to consider
when evaluating the potential use of genomics to identify risk for
PTSD in the military and making decisions based on this information.
Part II of this article provides a clinical overview of PTSD and
examines PTSD as a problem for service members and the military,
Part III examines some of the scientific challenges of establishing a
PTSD-PGS program and presents the current state of psychiatric and
PTSD genomics. Part IV considers some of the legal challenges
regarding the potential implementation of a PTSD-PGS in the
military, and Part V considers some of the important ethical
questions involved.

10.

JASON Report, supra note 3, at 1.

11.

Id. at 50.

12.

Id. at 43.

13.

See generally B.S. Wilfond & K. Nolan, National Policy Development for
the Clinical Application of Genetic Diagnostic Technologies: Lessons
from Cystic Fibrosis, 270 JAMA 2948 (1993) (describing issues linked
with the use of an extemporaneous model for health policy development
and arguing in favor of an evidentiary model).
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II. PTSD as Problem for Service Members and the
Military
PTSD can be triggered by exposure to actual or threatened death,
serious injury, or sexual violation. 14 However, PTSD is not just any
stress or aversive memory related to an actual or threatened
traumatic event. PTSD is a trauma- or stress-related disorder with
specific symptoms that must be present for at least one month. 15 A
PTSD diagnosis requires the presence of one or two symptoms from
each of the following symptom groups: Re-experiencing (e.g.
flashbacks, spontaneous memories or recurrent dreams of the
traumatic event); Avoidance (e.g. when an individual tries to avoid
trauma-related thoughts, feelings or external reminders of the event);
Negative cognitions and mood (e.g. persistent and distorted sense of
blame of self or others, persistent inability to experience positive
emotions, inability to remember key aspects of the traumatic event);
and Arousal (e.g. aggressive, self-destructive or reckless behavior,
exaggerated startle response, hypervigilance, problems with
concentration, and sleep disturbances). 16
The lifetime prevalence of PTSD in the U.S. general population is
estimated at 6.8%. 17 However, the prevalence among service members
is generally higher; for example, researchers estimate that 10% of Gulf
War veterans 18 and 13.8% of Operation Enduring Freedom and
Operation Iraqi Freedom veterans experience PTSD. 19 As one might
14.

National Center for PTSD: DSM-5 Criteria for PTSD, U.S. DEP’T VET.
AFF. (Jan. 3, 2014), http://www.ptsd.va.gov/professional/PTSDoverview/dsm5_criteria_ptsd.asp; AM. PSY. ASS’N, POSTTRAUMATIC
STRESS DISORDER: DSM-5 CHANGES IN PTSD CRITERIA 1 (2013),
http://www.psychiatry.org/File%20Library/Practice/DSM/DSM5/DSM-5-PTSD.pdf.

15.

See DSM-5 Criteria for PTSD, supra note 11.

16.

Id.

17.

Ronald C. Kessler et al., Lifetime Prevalence and Age-of-Onset
Distributions of DSM-IV Disorders in the National Comorbidity Survey
Replication, 62 ARCHIVES GEN’L PSYCHIATRY 593, 596 (2005).

18.

Han Kang et al., Post-Traumatic Stress Disorder and Chronic Fatigue
Syndrome-like illness among Gulf War Veterans: A population-based
survey of 30,000 Veterans, 157 AM. J. EPIDEMIOL. 141, 145 (2003).

19.

RAND, INVISIBLE WOUNDS OF WAR: PSYCHOLOGICAL AND COGNITIVE
INJURIES, THEIR CONSEQUENCES, AND SERVICES TO ASSIST RECOVERY 97
(Terry Tanielian & Lisa Jaycox eds., 2008) [hereinafter INVISIBLE
WOUNDS REPORT]; see generally INST. MED. NAT’L ACADS., TREATMENT
FOR POSTTRAUMATIC STRESS DISORDER
POPULATIONS: INITIAL ASSESSMENT (2012)

IN

MILITARY

AND

VETERAN

(stating that the percentage of
veterans that served in Afghanistan and Iraq that suffer from PTDS is
between 13% and 20%).
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expect, the incidence of PTSD among service members is closely
associated to traumatic events experienced during combat exposure.20
Therefore, due to the nature of their jobs, service members are
particularly at risk of being impacted by PTSD. In fact, PTSD was
the third-most common disability for veterans receiving compensation
in fiscal year 2012, after tinnitus and hearing loss. 21
The economic cost of mental health services is another aspect of
the burden of PTSD and other mental health disorders. The
estimated two-year cost of PTSD and major depression for 1.6 million
service members returning home from Afghanistan and Iraq is
between $4.0 billion and $6.2 billion, depending on whether that
statistic includes the value of lives lost to suicide mortality.22
Furthermore, the number of veterans needing mental health services
increased from 927,052 to 1.46 million over the last eight years, which
led the Department of Veterans Affairs (VA) to increase its mental
health care budget 39% from 2009 to 2013.23
PTSD symptoms not only lead to a large degree of suffering for
service members, but it also leads to suffering and difficulty for their
families. 24 In particular, PTSD often leads to impairments in
occupational functioning, which can limit service members’
effectiveness on the job and force them to take time off work for
treatment. 25 One concern among some military leaders is that PTSD
20.

Tyler C. Smith et al., New Onset and Persistent Symptoms of PostTraumatic Stress Disorder Self Reported After Deployment and Combat
Exposures: Prospective Population Based US Military Cohort Study, 336
BRIT. MED. J 366, 366 (2008); see Naomi Breslau, The Epidemiology of
Trauma, PTSD, and Other Postrauma Disorders, 10 TRAUMA, VIOL. &
ABUSE 198, 203 (2009).

21.

Richard J. McNally & B. Christopher Frueh, Why are Iraq and
Afghanistan War Veterans Seeking PTSD Disability Compensation at
Unprecedented Rates?, 27 J. ANXIETY DISORDS. 520, 520–21 (2013).

22.

INVISIBLE WOUNDS REPORT, supra note 15, at 200.

23.

U.S. DEP’T VET. AFF., 2013 PERFORMANCE AND ACCOUNTABILITY
REPORT I-2 (2013), http://www.va.gov/budget/report/ [hereinafter VA
P&A 2013 Report].

24.

Lisa Gorman et al., National Guard Families After Combat: Mental
Health, Use of Mental Health Services, and Perceived Treatment
Barriers, 62 PSYCHIATRIC SERVS. 28, 31 (2011); Abigail H. Gewirtz et
al., Posttraumatic Stress Symptoms Among National Guard Soldiers
Deployed to Iraq: Associations With Parenting Behaviors and Couple
Adjustment, 78 J. CONSULT. & CLIN. PSYCHOL. 599, 603 (2010); see
Suzannah K. Creech et al., Impact of Coping Style and PTSD on Family
Functioning After Deployment in Operation Desert Shield/Storm
Returnees, 26 J. TRAUM. STRESS 507, 507 (2013).

25.

Paula P. Schnurr & Carole A. Lunney, Work-Related Outcomes Among
Female Veterans and Service Members After Treatment of
Posttraumatic Stress Disorder, 63 PSYCHIATRIC SERVS. 1072, 1077–78
(2012); David A. Adler et al., Psychiatric Status and Work Performance
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can affect military readiness and effectiveness by decreasing available
manpower and military duty performance. 26 These issues, combined
with the economic cost of PTSD, make PTSD prevention an
important undertaking for DoD. A potential way to prevent or
minimize the economic and biopsychosocial burden of PTSD in the
military is to identify those service members who are at high genomic
risk for developing PTSD and assign them to missions that will
minimize their combat exposure or develop interventions that may
help to decrease their chances of developing PTSD. When considering
this possibility, one of the first steps should be to examine whether
genome-based PTSD risk prediction is currently possible, and if not,
to identify the scientific questions that remain to be answered before
that goal can be realized.

III. Scientific Challenges for PTSD Preventive
Genomic Sequencing
PTSD is a significant problem for the military, and in theory,
genomics holds much promise for improving PTSD risk prediction.27
However, in order to use genomics for PTSD risk prediction and make
important personnel decisions based on this information, the military
needs a solid scientific foundation that will allow it to reliably predict
these risks. Recent developments in genomic technologies and
psychiatric genomics research may eventually provide the military the
genomic intelligence necessary to more reliably predict the risk of
PTSD among service members. But, the field of psychiatric genomics
cannot currently provide this robust scientific foundation, and it will
probably not be able to do this for a number of years.
A. Psychiatric Genomics

To understand why reliable PTSD risk prediction based on
genomics is not currently possible, and may not be for some time, we
need to briefly examine the recent development and current state of
psychiatric genomics. Uncovering the genomics of psychiatric
disorders such as PTSD has proven to be a challenge. 28 Psychiatric
of Veterans of Operations Enduring Freedom and Iraqi Freedom, 62
PSYCHIATRIC SERVS. 39, 40 (2011).
26.

See Michael P. Fisher, PTSD in the U.S. Military, and the Politics of
Prevalence, 115 SOC. SCI. & MED. 1, 5 (2014).

27.

See Nadia Solovieff et al., Genetic Association Analysis of 300 Genes
Identifies a Risk Haplotype in SLC18A2 for Post-traumatic Stress
Disorder in Two Independent Samples, 39 NEUROPSYCHOPHARM. 1872,
1876 (2014).

28.

See generally Steven A. McCarroll et al., Genome-Scale Neurogenetics:
Methodology and Meaning, 17 NAT. NEUROSCI. 756, 761 (2014)
(concluding that while finding genomic markers for psychiatric disorders
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disorders are complex diseases in which numerous genes and
environmental factors play a role. In fact, even though the
contribution of genomics is substantial, 29 environmental factors, such
as exposure to stress or traumatic events, are believed to play a more
prominent role in determining the risk for psychiatric disorders. 30
Part of the difficulty in uncovering the genomics of psychiatric
disorders stems from the fact that numerous genes are involved and
each of these genes contributes only a small amount to the overall risk
of developing a psychiatric disorder. 31 In addition, individuals can
have different combinations of genes that put them at risk, and these
genes interact with other genes and environmental factors to shape
overall risk. 32 The small contribution of individual genes to the overall
risk of developing a psychiatric disorder means that researchers need
to examine very large samples of subjects with psychiatric disorders.
Then, they need to compare their genetic profiles to carefully selected
controls in order to obtain the statistical power necessary to detect
the contribution of these genes (hereafter referred to as the “statistical
power” problem). 33
As a further complication, there are more than 20,000 proteincoding genes in the genome. Thus, in the pursuit of genes that are
associated with psychiatric disorders, researchers face a challenging
needle-in-a-haystack problem as well. For years, researchers tried to
formulate informed hypotheses about which genes could contribute to
the overall risk for a psychiatric disorder in order to focus their
research on those genes that they believed were more likely to play a

has progressed since 2009, when a more complete human genome was
finally mapped, this is still in a nascent stage); see Stephen B. Manuck
& Jeanne M. McCaffery, Gene-Environment Interaction, 65 ANN. REV.
PSY. 41, 61 (2014); see Karestan Koenen et al., From Candidate Gene
to Genome-wide Association: The Challenges and Promise of
Posttraumatic Stress Disorder Genetic Studies, 74 BIOL. PSYCHIATRY
634, 635 (2013).
29.

See Patrick F. Sullivan et al., Genetic Architectures of Psychiatric
Disorders: The Emerging Picture and its Implications, 13 NAT. REVS.
GEN. 537, 538 (2012); see Roger K. Pitman et al., Biological Studies of
Post-Traumatic Stress Disorder, 13 NAT. REVS. NEUROSCI. 769, 777
(2012).

30.

Teri A. Manolio, Bringing Genome-Wide Association Findings Into
Clinical Use, 14 NAT. REVS. GEN. 549, 551 (2013).

31.

See id.; see McCarroll et al., supra note 25, at 761; see Manuck &
McCaffery, supra note 25, at 42.

32.

See Manuck & McCaffrey, supra note 25, at 42.

33.

Aiden Corvin et al., Genome-Wide Association Studies: A Primer, 40
PSYCHOL. MED. 1063, 1070–72 (2010).
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role. 34 Unfortunately, this candidate gene approach has proven
inefficient and generated numerous inconsistent and contradictory
findings. 35
B. How are Psychiatric Genomics Addressing these Challenges?

In recent years, researchers have begun to perform large-scale
genome-wide association studies (GWAS) to address the statistical
power and needle-in-a-haystack problems. 36 GWAS studies address
the needle-in-a-haystack problem because, unlike candidate gene
studies, they follow a hypothesis-free approach by examining large
numbers of genes without an a priori determination of which genes
might have any predictive value for psychiatric disorders. 37
Even though GWAS help address the needle-in-a-haystack
problem, this approach involves a great number of statistical tests,38
which exacerbate the statistical power problem in psychiatric
genomics. This means that GWAS for psychiatric disorders require
even larger samples than candidate gene studies. Therefore, in order
for GWAS to detect the many genes that make a small but significant
contribution to the overall risk for psychiatric disorders, GWAS need
samples that can be in the order of thousands of case and control
subjects—perhaps even into the tens or hundreds of thousands.39
Conducting these large-scale GWAS involves a great amount of
resources and coordination that single research projects are often
unable to achieve and therefore progress in psychiatric genomics can
be slow.
In recent years, psychiatric genomics researchers have begun
developing conglomerates, such as the Psychiatric Genomics
Consortium in order to pool resources and datasets. 40 This approach
34.

See Koenen et al., supra note 25, at 634–35; see McCarroll et al., supra
note 25, at 756–57; see Pitman et al., supra note 26, at 769-70.

35.

See Pitman et al., supra note 26, at 777; Marylin C. Cornelis et al.,
Genetics
of
Post-Traumatic
Stress
Disorder:
Review
and
Recommendations for Genome-Wide Association Studies, 12 CURR.
PSYCHIATRY REPS. 313, 314 (2010).

36.

Corvin et al., supra note 30, at 1063; Anna C. Need & David B.
Goldstein, Schizophrenia Genetics Comes of Age, 83 NEURON 760, 760–
61 (2014).

37.

See Corvin et al., supra note 30, at 1072.

38.

Id. at 1071.

39.

See id.; see Koenen et al., supra note 25, at 634; Schizophrenia Working
Grp. Psy. Genomics Consortium, Biological Insights from 108
Schizophrenia-Associated Genetic Loci, 511 NATURE 421, 421 (2014)
[hereinafter PGC Schizophrenia Nature 2014].

40.

Psychiatric Genomics Consortium, UNIV. N. CAR. SCH. MED. (2014),
http://www.med.unc.edu/pgc.
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has allowed researchers to combine sets of GWAS data in order to
conduct mega-analyses for a number of psychiatric disorders. 41 The
result of this large-scale GWAS and GWAS mega-analyses approach
has been unprecedented advances in uncovering some of the genetic
bases of schizophrenia 42 and to a lesser extent bipolar disorder, major
depressive disorder, attention deficit hyperactivity disorder, and
autism. 43 They have also identified a number of genes that play a role
across numerous psychiatric disorders. 44 However, these large-scale
GWAS and mega-analyses approaches have not yet been applied to
PTSD genomics.
C. What about PTSD Genomics?

Genomic influences account for 30% 45 to 70% 46 of the risk for
PTSD, but PTSD genomics research has confronted the same
statistical power and needle-in-a-haystack problems described above
for research with other psychiatric disorders, together with a number
of other complications particular to PTSD. 47 For example, PTSD
studies are not consistent in the way they define cases of PTSD or the
characteristics of the control groups, some researchers use traumaexposed controls while others do not. 48
To date, PTSD genomics research has relied mostly on candidate
gene studies. 49 Although these studies have identified more than
twenty genes associated with PTSD such as SLC6A4 (also known as
5HTTLPR), DRD2, FKBP5, and PACAP, many consider these
findings suspect because of how difficult it has been to replicate

41.

Sullivan et al., supra note 26, at 543.

42.

See Need & Goldstein, supra note 33, at 762; PGC Schizophrenia
Nature 2014 supra note 36, at 424.

43.

See Psychiatric Genomics Consortium: Results, UNIV. N. CAR. SCH.
MED. (2014), http://www.med.unc.edu/pgc/results.

44.

Cross-Disorder Grp. Psy. Genomics Consortium, Identification of Risk
Loci with Shared Effects on Five Major Psychiatric Disorders: A
Genome-Wide Analysis, 381 LANCET 1371, 1375–78 (2013).

45.

Murray B. Stein et al., Genetic and Environmental Influences on
Trauma Exposure and Posttraumatic Stress Disorder Symptoms: A
Twin Study, 159 AM. J. PSY. 1675, 1675 (2002).

46.

Carolyn E. Sartor et al., Common Genetic and Environmental
Contributions to Post-Traumatic Stress Disorder and Alcohol
Dependence in Young Women, 41 PSYCHOL. MED. 1497, 1502–03 (2011).

47.

See Solovieff et al, supra note 24, at 1876–77; see Koenen et al, supra
note 25, at 635–36; see Pitman et al, supra note 26, at 780, 783; see
Cornelis et al., supra note 32, at 323.

48.

See Solovieff et al., supra note 24, at 1873.

49.

See Stein, supra note 42, at 1675.
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candidate gene PTSD studies. 50 In contrast, large-scale GWAS and
GWAS mega-analyses studies of schizophrenia have identified more
than 350 genes that are reliably implicated in schizophrenia. 51 Some
PTSD GWAS studies have begun to emerge in the literature. 52 These
studies have identified some new genes and provided evidence for the
association of others that had been reported in candidate gene
studies. 53 However, PTSD GWAS studies have used relatively small
samples, which as recognized by the authors of these studies is a
limitation that needs to be addressed in order to advance the field of
PTSD genomics. 54
Fortunately, efforts are underway by prominent researchers to
develop large-scale GWAS and mega-analyses for PTSD within the
Psychiatric Genomics Consortium. 55 These efforts should help speed
the process of uncovering the genomics of PTSD and these are not the
only ongoing large-scale efforts. The VA is currently taking advantage
of developments in MPS technologies, which have decreased the cost
of WES, to help lead the charge towards uncovering the genomics of
PTSD. In 2011, the VA launched the Million Veteran Program
(MVP) “a ground-breaking genomic medicine program, [which]
endeavors to collect genetic samples and general health information
from 1 million Veterans in the next 5-7 years.” 56 MVP’s goal is “to
study how genes affect health…[d]ata collected from MVP will be
stored anonymously for research on diseases like diabetes and cancer,
and military-related illnesses, such as post-traumatic stress
disorder.” 57 As of September 30, 2013 more than 200,000 veterans
have enrolled in MVP and the project has begun sequencing of the
first samples. 58

50.

Id.

51.

See Need & Goldstein, supra note 33, at 761.

52.

See Solovieff et al., supra note 24, at 1877; Pingxing Xie et al., GenomeWide Association Study Identifies Susceptibility Loci for Posttraumatic
Stress Disorder, 74 BIOL. PSYCHIATRY 656, 661 (2013); see Guia
Guffanti et al., Genome-Wide Association Study Implicates a Novel
RNA Gene, the lincRNA AC068718.1, as a Risk Factor for PostTraumatic
Stress
Disorder
in
Women,
38
PSYCHONEUROENDOCRINOLOGY 3029, 3030 (2013).

53.

See Solovieff et al., supra note 24, at 1877.

54.

See id.; Xie et al., supra note 49, at 661; see Guffanti et al., supra note
49, at 3036.

55.

See Koenen et al., supra note 25, at 634.

56.

VA P&A 2013 Report, supra note 20, at Part I-19.

57.

Million Veteran Program, supra note 4.

58.

VA P&A 2013 Report, supra note 20, at Part I-19.
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While the identification of genomic variants that reliably predict
high risk for PTSD or the integration of genomic information into risk
prediction models for PTSD is probably a few years away, efforts such
as the Psychiatric Genomics Consortium’s PTSD Working Group,
and the VA’s MVP, are helping pave the way. Furthermore, given
that the prospect of implementing a PTSD-PGS program in the
military is currently being considered, it is important to begin
examining some of the most relevant legal and ethical challenges these
programs may generate. The following sections examine these issues.

IV. Legal Challenges for implementing a PTSD-PGS
Program in the Military
Many of the legal and ethical considerations in establishing a
PTSD-PGS program are dependent on the way such program would
be implemented and how the military would use the information
collected. To discuss this, one should assume, with the JASON
report, 59 that: such a program would employ DNA sequencing
technologies such as MPS at the whole genome or whole exome (WGS
or WES) levels; that participation in the program would be a
requirement for all service members; and that the resulting genomic
information about PTSD risks would be used for determining service
assignments for military personnel. Each of these initial assumptions
bears explanation before proceeding.
We assume that a PTSD-PGS program in the military would
employ WGS or WES, instead of more limited targeted sequencing,
because of the number of genes the military would need to examine to
offer useful predictions and the range of phenotypes that the military
would be interested in examining. 60 For example, given that PTSD is
a complex disorder, predicting the risk of PTSD is likely to involve
sequencing a large number of genes in different regions of the genome.
Furthermore, in addition to PTSD, the JASON Report suggests that
the military would be interested in a wide range of other phenotypes
that would be relevant for military duty such as “the ability to
tolerate conditions of sleep deprivation, dehydration, or prolonged
exposure to heat, cold, or high altitude, or the susceptibility to
traumatic bone fracture, prolonged bleeding, or slow wound
healing.” 61 Although panels of specific genes implicated in PTSD and
all of these phenotypes could be created for targeted sequencing, on a
mass scale, it will be much more cost efficient to sequence entire
59.

JASON Report, supra note 3, at 4 (recommending that the DoD
Military Health System should “[p]lan for the eventual collection of
complete human genome sequence data from all military personnel.”).

60.

JASON Report, supra note 3, at 43.

61.

Id.
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genomes or exomes at once, even if the resulting data is only queried
for PTSD risk variants.
Second, we assume that a PTSD-PGS would be a requirement for
all service members because, as with a universal vaccination scheme,
an overcompensation strategy would likely be the most effective
method for minimizing the risk of PTSD. Identifying high risk
personnel that could face environments where there is a high
likelihood of experiencing traumatic events would be useful, and it
would be relatively harmless to discover that personnel in low stress
environments are at low genomic risk for PTSD.
Finally, in the absence of effective biomedical prophylaxis or
treatment for PTSD, one of the principal reasons for establishing a
PGS program would be to use genomic information to make service
assignments by determining which service members are most likely to
succeed in a particular mission and less likely to suffer harms such as
PTSD. 62 The military already uses information about genetic
conditions such as sickle cell and G6PD deficiency to determine
assignments so a PTSD-PGS program would likely be used to extend
this practice. 63
The most serious legal concerns raised by a PTSD-PGS program
are issues related to genetic discrimination and invasion of privacy.
We will first examine the concerns about genetic discrimination.
While the goal of using genomics to minimize the risk of PTSD may
be noble, achieving this goal may involve discriminating against
asymptomatic service members on the basis of their genomic
information. For example, if the PTSD-PGS identified Private
Williams as being at high risk for developing PTSD, his superiors
could decide to assign him to duties where he would not be exposed
to combat or to missions in which combat exposure was expected to
be low. While this would likely minimize Private Williams’ risk of
developing PTSD, it would also negatively impact his prospects of
getting promotions. This may be particularly difficult to accept for
Private Williams, and others like him, because they would be denied
certain opportunities based on genomic risks that may never
materialize, and not the presence of actual symptoms that limit their
capacity to perform their job.
In the civilian context, of course, the Genetic Information
Nondiscrimination Act of 2008 (“GINA”) prohibits employers from
using genomic information to assign employees to certain jobs. 64 In
62.

Id.

63.

See Nunes supra note 5.

64.

Genetic Information Nondiscrimination Act of 2008, Pub. L. No. 110233, 122 Stat. 881 [hereinafter GINA]; Mark A. Rothstein, GINA, the
ADA, and Genetic Discrimination in Employment, 36 J. L. MED. &
ETHICS 837–38 (2008); Mark A. Rothstein, Genetic Discrimination in
Employment is Indefensible, HASTINGS CTR. REP., Nov.-Dec. 2013, at 3,
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fact, GINA prohibits employers from even requesting that employees
undergo any kind of genetic testing or that they disclose the results of
genetic tests. 65 However, GINA does not apply to the United States
military. 66 Therefore, if the military implemented a PTSD-PGS
program, service members like Private Williams would not be able to
assert the protections afforded to civilians under GINA. Nevertheless,
Private Williams may be able to argue that this practice violates the
Constitution, by appealing to the Equal Protection clause.
A. Equal Protection

Service members who are denied certain assignments based on
their genomic information could claim that these genome-based
decisions constitute genetic discrimination that violates the equal
protection principles found in the due process clause of the Fifth
Amendment. 67 Service members could claim, for example, that the
program has a discriminative motive, that of either identifying and
terminating service members with supposedly inferior genomes from
service, or denying them certain opportunities. If the information
generated by the program is used to determine assignments, service
members could also claim that the application of the program
discriminates against service members who are physically and
emotionally fit for assignments, but have some genomic variants that
indicate that in the future they might develop certain conditions such
as PTSD. In that sense, the program would treat similarly situated
individuals (at least in terms of phenotype) differently based solely on
their genomic profiles. Finally, service members could argue that there
is no justification or rational basis for denying them certain
opportunities because they currently have no symptoms, and the
genetic contribution to the risk of complex diseases like PTSD is
relatively small compared to the contribution of environmental
factors. Therefore, their genomic information does not allow the
military to make the reliable predictions necessary to protect its
interests in minimizing health risks for service members and
improving or maintaining military readiness.
3 (2013); but see Noah Levin, A Defense of Genetic Discrimination,
HASTINGS CTR. REP., Jul.-Aug. 2013, at 33 (2013) (arguing that genetic
discrimination in employment should be allowed in some cases).
65.

GINA, supra note 61, at § 202(b).

66.

See Baruch & Hudson, supra note 6, at 439.

67.

See United States v. Windsor 133 S. Ct. 2675, 2695–96 (2013) (ruling
that the federal government could not discriminate against staterecognized same-sex marriages and, by extension, the individuals in such
marriages); Bolling v. Sharpe 347 U.S. 497, 500 (1954) (extending the
prohibition on racial discrimination to the federal government by
striking down racial discrimination in District of Columbia Public
Schools).
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While some of these arguments may be persuasive, particularly if
they were made in a civilian context, it may be difficult to convince
courts to restrict the military’s collection and use of genomic
information. Traditionally, courts have been highly deferential to the
military (a practice known as the military deference doctrine)
regarding regulations and practices that may impinge on service
member’s constitutional rights, but the military considers important
for military readiness. 68 This deference is generally based on three
arguments:
(1) military authorities are uniquely able to determine the
unique needs of the armed forces in crafting military
regulations; (2) courts are ill-equipped to determine the impact
upon discipline that any particular intrusion upon military
authority might have; and (3) military commanders have been
charged by Congress and the President with carrying out the
national military policy, and both of those branches have been
conferred that power explicitly by the Constitution. 69
B. Invasion of Privacy: Lessons from DoD DNA Registry

If the military established a PGS program, service members could
also argue that the collection and analysis of their genomic
information constitutes a violation of their privacy rights. In order to
evaluate this claim it is important to consider relevant precedents. In
1991 DoD initiated a DNA Registry to collect and store blood and
saliva samples from all service members for the purposes of remains
identification. 70 Soon after the program began, two servicemen refused
68.

See generally John F. O’Connor, The Origins and Application of the
Military Deference Doctrine, 35 GA. L. REV. 161 (2000) (characterizing
the Supreme Court’s traditional military deference as rooted in a
reading of the Constitution that allowed the military to act as needed
under the president’s Art. II authority as commander-in-chief of the
military); see generally Steven B. Lichtman, The Justices and the
Generals: A Critical Examination of the U.S. Supreme Court’s
Tradition of Deference to the Military, 1918-2004, 65 MD. L. REV. 907
(2006) (analyzing the Supreme Court’s deference to the military through
the lens of affirmative action); but see John F. O’Connor, Statistics and
the Military Deference Doctrine: A Response to Professor Lichtman, 66
MD. L. REV. 668, 672 (2007) (arguing, inter alia, that although the
Supreme Court does give deference to the military in its decisions, the
deference is rooted in a reading of the separation of powers rather than
a general policy of always deferring to military leadership when the
articulate their opinions on the outcome of a case).

69.

See O’Connor, supra note 65, at 270.

70.

Mayfield v. Dalton 901 F. Supp. 300, 302 (Haw. 1995); see also Armed
Forces Repository of Specimen Samples for the Identification of
Remains (AFRSSIR), ARMED FORCES MED. EXAMINER SYS. (Aug. 21,
2014), http://www.afmes.mil/index.cfm?pageid=doddr.afrssir.overview.
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to provide specimen samples for the DNA Registry and challenged the
constitutionality of the program. 71 While the district court’s decision
was eventually vacated as moot because the servicemen were
honorably separated from active duty, the plaintiffs’ arguments are
illustrative of the kinds of challenges a more comprehensive genomic
sequencing program could face if implemented in the military.
The servicemen’s strongest argument in Mayfield v. Dalton was
that the specimen collection constituted an unreasonable seizure for
the purposes of the Fourth Amendment. 72 However, the court held
that the collection of specimens “for the military’s DNA registry,
though undoubtedly a “seizure,” is not an unreasonable seizure and is
thus not prohibited by the Constitution.” 73 The court favorably cited
cases noting that military personnel have a diminished expectation of
privacy; found that specimen collection is a relatively limited
invasion; and considered that the restricted purpose of the program
(i.e. remains identification), and the compelling interest protected (in
the instance of remains identification, “confirm which of its members
has fallen in battle[,] . . . may have been taken prisoner or are
otherwise unaccounted for [and being able to provide] solace [to the
relatives of fallen servicemen, via the] speedy and definite
identification of the remains of their loved ones” 74) make the specimen
collection a reasonable seizure under the Fourth Amendment. 75
Interestingly, one of the plaintiffs’ claims in Mayfield was that the
military could expand its use of the specimens collected. They argued
that at some point the military could “use the DNA samples for some
less innocuous purpose, such as the diagnosis of hereditary diseases or
disorders.” 76 The court found that the plaintiffs presented no evidence
that the military had used or planned to use the samples for any
purpose other than remains identification, thus “[a] challenge to such
hypothetical future use, or misuse . . . does not present a justiciable
case or controversy.” 77
C. Unreasonable Seizure of Genomic Information

Twenty years after the plaintiffs in Mayfield raised concerns about
other potential uses of genetic information, military advisors, such as
the authors of the JASON Report, are discussing the possibility that
71.

Mayfield, 901 F. Supp. 300, vacated as moot, 109 F. 3d 1423 (9th Cir.
1997).

72.

Id.

73.

Mayfield, 901 F. Supp., at 304 (emphasis from original).

74.

Id.

75.

Id.

76.

Id.

77.

Id.
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the DoD might establish a genomic sequencing program, which could
potentially be used for predicting a service member’s risk for
developing PTSD. This type of program would be more challenging
from a Fourth Amendment standpoint because it could be argued
that the broader kind of information sought and the multiple
potential uses of this information would make the unconsented seizure
of a blood or saliva sample for the genomic sequencing program
unreasonable. As with DoD’s DNA Registry, the PTSD-PGS would
involve the collection of blood or saliva samples, thus in this sense the
physical intrusion upon service members would not be any worse than
what the DNA Registry program requires. However, in this nascent
era of genomics, limiting any Fourth Amendment analysis that
involves genetic or genomic testing to whether the collection of blood
or saliva is a reasonable seizure given the government’s interests,
would completely ignore the core issue that is really at stake: the
seizure of genomic information.
What would make the collection of samples for the PTSD-PGS
program more invasive than the DNA Registry—and perhaps
unreasonable in terms of the Fourth Amendment—is the kind of
information extracted from these blood or saliva samples and how the
military is expected to use that information. PTSD-PGS would likely
employ WGS or WES, meaning that DoD would collect DNA
sequencing data from the entire genome (WGS) or all-protein coding
genes in the genome (WES). Either way, the raw DNA data collected
by WGS or WES would be much broader than the genetic
information extracted from blood or saliva samples for the purposes of
remains identification. WGS or WES data would allow the military to
determine all of a service member’s medical genomic risks known in
the scientific literature, including risks and predispositions that are
unrelated to his or her fitness for military duty.
Furthermore, the purpose of the PTSD-PGS program would be to
determine health risks and the likelihood of phenotypes and traits
relevant for military duties in order to decide whether a service
member is fit for duty or at least how equipped the service member
may be for particular assignments from a genomic standpoint. 78 This
information would have much broader implications for a service
member’s entire military career than the identification of his or her
remains. The information could be used to determine assignments,
which could limit the ways in which service members could serve, and
negatively impact their opportunities for getting promotions and
advancing their military careers.
On the other hand, regardless of how invasive WGS/WES may
be, the military can argue that it has some very compelling interests
to protect with PSTD-PGS, primarily concerning the health and well
78.

JASON Report, supra note 3.
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being of service members, and military readiness. These compelling
interests, combined with the military deference doctrine, may mean
that in practice the only viable option for service members looking to
significantly limit the scope of a military genomic sequencing program
and the way this information is used would not be through the courts.
Rather, they may need to convince Congress to regulate the collection
and use of genomic information in the military. 79
D. Unreasonable Search of Genomic Information

Interestingly, even if courts held that the seizure of samples for a
military genomic sequencing program was reasonable, service
members may be able to argue that certain searches within their
genome would be unreasonable. For instance, service members could
argue that the genomic information sought and analyzed by a
military’s WGS/WES program should be limited to sequencing
information directly related to military readiness or the minimization
of health risks that may be prompted or exacerbated by military
duty. Even when WGS or WES is performed, laboratories have the
bioinformatics capacity to determine which genes are analyzed and
interpreted in order to determine specific health risks. Therefore, it is
possible to restrict the information sought and analyzed by the
military to that relevant to military duty and readiness. One problem
with this could be finding an adequate way to define which genomic
information is sufficiently related to military readiness. If defined too
broadly, it may intrude into elements of the service member’s health
that have little bearing on their ability to perform their mission.
However, it seems like the search and analysis of genes such as those
closely associated with colon cancer (e.g. MLH1, MSH2, MSH6, and
PMS2) or hereditary breast and ovarian cancer (e.g. BRCA 1 and
BRCA 2) could be considered an unreasonable invasion of service
members’ intimacy unless consented.

V. Ethical Challenges
The prospect of a PTSD-PGS program also raises a range of
ethical and social challenges that will require consideration by DoD, if
the agency is to comply with the JASON Report’s prescriptions for
military genomics. These range from questions about the impact of
implementing such a program on the units to which individual service
people belong, to issues at the interfaces of the military with civilian
society, to challenges in the design and implementation of the
research necessary to develop evidence-based PGS programs in the
first place.

79.

See GINA, supra note 61.
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A. Unit Cohesion and Fair Distribution of Combat Risk

One of the interesting features of the military is that it is one of
the few American social spheres where the rights and interests of the
individual do not come first. As William Rhodes articulates in his
introduction to military ethics:
As a result, militaries put tremendous emphasis on an ethical
requirement to value the needs of one’s group above personal
desires. Sometimes this is referred to, as in military “core
values” statements, as the virtue of selflessness. In its highest
manifestation, an individual’s identification with his unit is so
thoroughgoing that he sees little distinction between the unit’s
well-being and his own . . . . Fear of failing one’s subordinates
or failing to accomplish the mission that others are depending
on become predominant ethical worries. 80

On one hand, this means that many of the usual autonomy-based
bioethical worries over preventive genomic sequencing (the need for
adequate individual informed consent to sequencing, rights to know or
not know sequencing results and incidental findings, the privacy of
these findings, etc.) are, if not moot in the active duty context, at
least relocated from individuals to the commanders responsible for
their best interests. If the chain of command concurs that the privacy
costs and discrimination risks of PGS are proportionate to the
mission-oriented benefits that relevant military cohorts could garner,
our civilian fixation on personal freedoms of opportunity and selfdetermination would not stand in the way.
On the other hand, as Rhodes stresses, privileging the interests of
the cohort over the individual also generates a commitment, on the
part of both commanders and subordinates, to the cohesion of the
unit and a mutuality of effort within it. Teamwork is prized and its
opposite is castigated as “shirking”: contriving to relieve oneself of
duty to avoid one’s group obligations. As sympathetic as Corporal
Klinger’s cross-dressing efforts gain a psychiatric
“Section 8”
discharge from his M.A.S.H. duties were for his American TV
audience in the 1970’s, he was not behaving like a good soldier.
Moreover, his vice was not cowardice: it was that his group needed
him to fulfill their mission, which would suffer from his departure.
In this context, a commander contemplating a PTSD-PGS in an
otherwise asymptomatic cohort faces an ethical challenge: would it be
fair to the unit to reassign soldiers to noncombat roles on the basis of
probabilistic, but unproven, risk of downstream PTSD? First of all, if
genetic markers for PTSD risk are as common in the population as
the incidence of the disorder suggests, this could itself have a
80.

WILLIAM RHODES, AN INTRODUCTION TO MILITARY ETHICS 54 (2009).
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destabilizing effect on the unit as whole. Should all cases of PTSD
risk be treated alike for reassignment purposes, or could key personnel
– e.g. the Tank Commander, the Demolitions Expert, the IT Expert-be kept in their combat roles on other grounds of military necessity
regardless of their genomic status? These decisions are exacerbated,
secondly, by the fact that the benefits of PTSD-PGS to any particular
cohort or unit are never going to be directly mission-related. To the
extent that PTSD is a most often a delayed onset condition, a
preventive screening program may be in at-risk individuals’ eventual
health interests, and could certainly benefit the military veterans
health care system by saving downstream costs. But it is not clear
how it can help a unit meet its primary military objectives. In fact,
since the ordinary and expected risks of combat are more severe and
predictable than a genomic risk of PTSD, a program that allows (or
forces) soldiers to avoid the former in the name of avoiding the latter
may look more like a shirkers’ lottery than a humane service, at least
to those left to face the trial of combat. In sum, by disrupting unit
cohesion and relieving asymptomatic soldiers of their ordinary risktaking obligations, such a program may appear to commanders like a
disproportionate risk to their unit’s functionality, even if its risks to
its individual recipients are negligible. If commanders are to take the
morale and mission-readiness of their units as their primary concern,
this may simply relocate what might be considered “autonomy-based”
ethical challenges to mounting universal PTSD-PGS upwards within
chains of command as issues of professional integrity for unit
commanders. 81
B. During Active Duty, Training, or Recruitment?

Perhaps the foregoing concerns indicate that active duty
personnel who already belong to mission-oriented military units are
simply the wrong target for PTSD-PGS. If PTSD risk information
was collected and used earlier in a service person’s military life,
during training, for example, units themselves could be composed of
either high and low risk personnel from the start, depending on their
missions, in the way that aptitude tests are already used to assign
new recruits to different kinds of military vocations. Or, to take a
step further back, why not employ the PGS during recruitment, to
pursue a “PTSD-free” military across the board?
Conducting PTSD-PGS during military training has attractions
similar to newborn genetic screening in the public health context. 82

81.

Maj. William. H. Margerum, Integrity: the military professional and society,
AIR UNIV. REV.(Sept, 1983), http://www.airpower.maxwell.af.mil/
airchronicles/aureview/1983/sep-oct/margerum.html.

82.

See generally Mary Ann Baily & Thomas Murray, Ethics, Evidence, and
Cost in Newborn Screening, HASTINGS CTR. REP., May-Jun. 2008, at 23
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Detected early enough, the long-term harms of a recruit’s genomic
vulnerabilities could be taken into account even in developing their
military life-plan, by putting them on a low-stress diet of stateside
desk jobs and support missions that would avoid the environmental
triggers of their (possible) predisposition. This approach would take
the program’s risk/benefit calculations out of the (benignly
paternalistic) hands of unit commanders, avoid the unit cohesion and
shirking issues, and make it easier to justify implementing PTSD-PGS
universally across the military, rather than just for those most likely
to encounter the environmental triggers of PTSD.
On the other hand, this would create a bifurcated military, with a
class of behind-the-lines support units composed heavily of PTSDvulnerable recruits, and a combat class composed of recruits of
unknown PTSD risks. In the hierarchical and specialized world of the
military, this bifurcation in itself may be no cause for moral alarm.
But it could run afoul of two important military moral values that
would make it problematic. The first is the principle of military
advancement through merit. 83 If one’s genomic classification places a
permanent bar on certain military career paths, it compromises the
ability of service people to “work themselves up from the ranks” to
leadership positions. The perception that the military embraces and
empowers personal initiative by its members to overcome their own
limitations, and “be all they can be” despite the vagaries of their
social backgrounds is important both to its members sense of
solidarity and its external recruitment efforts. Mandatory genomic
sorting could damage that perception on both fronts, especially if
people thought that only those on the “high stress track” would have
important opportunities to demonstrate military virtues like courage,
self-sacrifice, leadership and strength, in ways that count as military
heroism. 84 This risk, in turn, reflects the other value at stake: the
opportunity that the military offers recruits to leave the unjust
prejudices of civilian society behind, in favor of a system without
systematically favored groups defined on mission-irrelevant grounds.
The military’s internal sense of fairness demands that no one should
be denied the opportunity to prove themselves if they can “pass
muster” for the job at hand, regardless of their biological

(describing the history, current practice, and suggested limitations on
neonatal genetic screening).
83.

DARLINE ISKRA, BREAKING THROUGH THE BRASS CEILING: STRATEGIES OF
SUCCESS FOR ELITE MILITARY WOMEN (2008).

84.

SHANNON FRENCH, THE CODE OF THE WARRIOR: EXPLORING WARRIOR
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background. 85 Doing so on the basis of their genomic foreground, the
argument would go, seems just as discriminatory.
One possible way out of these conundrums is suggested by the
newborn screening analogy. For the case of phenylketonuria risk
screening in newborns, at least, the idea is to follow the early
detection of PKU risk with a special diet designed to protect the
patient’s brain from a poisonous accumulation of phenylketones
during its postnatal development, after which a normal diet can be
resumed. If a sequence-informed service assignment were not
permanent, but capable of being “tested out of” by doing well with
regimen of hypothetical PTSD “challenges,” perhaps its threat to the
military’s meritocractic ethos could be avoided. But even such a
regimen of special vetting could endanger another important military
ethical commitment if it came to reflect negatively on “low stress”
service careers themselves.
A corollary of the military values of opportunity and fairness is
that, in (military ethical) theory, low stress but critical military
support operations should enjoy the same prestige as combat units,
and afford equally honorable opportunities for leadership and
heroism. 86 Given the military’s veneration of warrior heroes, it is a
continuing psychosocial challenge to inculcate and promote this
principle of equity, both within military circles and in the wider
society. It would undermine that effort if a genomic sorting program
early in a military career carried a perceived stain of weakness to
those in non-combatant military career paths. But unlike other
disabilities, such as an amputation, or even other genetic
vulnerabilities, like Long Q-T syndrome, PTSD is about a soldier’s
resilience in the face of the kinds of trauma strong soldiers are
expected to face. It has a direct connection to core mission-related
military virtues that makes it particularly potent as a vulnerability
and stigmatizing to the service assignments with which it becomes
associated.
One way to try to avoid all these worries would be to use PGS
even earlier during recruitment, to help build a military that has as
few personnel at high risk for PTSD as possible. If targeting PTSDPGS to trainees is like newborn screening, this approach could be
analogized to prenatal screening: its goal would be to select out only
those recruits who do not show the PTSD markers, and reject those
who do from military service altogether, in a genomic version of the
old 4F exclusion.

85.

ISAAC HAMPTON, THE BLACK OFFICER CORP: HISTORY OF BLACK
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As appealing as this approach appears from inside the military,
however, it does face significant social challenges. Now we are in the
situation of performing genomic sequencing on individuals who are
not yet part of the military and still retain their full panoply of
autonomy rights. Even if the armed services could, in the face of the
ADA and the Equal Protection clause, legally make the absence of
genomic markers for PTSD risk a prerequisite for recruitment into
military employment, the moral case for genetic discrimination
against would-be volunteers who carry the risk markers would be
strong, given the many military occupations in which such recruits
could excel without risk to the military’s mission. Moreover, in
performing PTSD-PGS on civilians, recruiters would face all the
challenges now being encountered in clinical and public health
settings in which WGS/WES is being implemented. 87 Fully informed
consent to the sequencing would be morally required, including
disclosures concerning the psychosocial risks as well as the benefits of
identifying PTSD markers and other genomic information that may
be examined. Plans for managing incidental and secondary target
findings, especially medically actionable findings, would need to be in
place. Questions about the storage and disposition of their sequence
data would need to be addressed, especially for those who are rejected
or decline to join the military for other reasons. Would their data be
expunged, or placed under their control in some other way? What
privacy protections would it enjoy during its analysis and use by the
military recruiters? Those who currently aspire to use sequencing
technologies in civilian clinical and public health settings are already
besieged by the complexity of these challenges. If the attempt to
manage them for the purposes of military recruitment simply
compounds the public relations challenge of proposing to use genomic
screening to insure a military without PTSD, the whole approach
begins to look doubtful.
C. Genetic Essentialism and Post-Service Stigmatization

The problem with using PTSD-PGS as a recruitment screen is
that it has to happen at the interface of the civilian and military
moral spheres, where civilian values still have purchase. Another set
of related issues arise at the other end of a military career, after a
discharge from the armed services. As the VA exemplifies, the
military’s ethical obligations to its personnel extend well beyond their
active service. Conscientious military planners will have to consider
the implications of PTSD-PGS for veterans in their post-military
civilian lives. If carrying PTSD risk markers is a serious enough
87.

See generally
PRIVACY AND
(recommending
improved while

PRESIDEN’L COMM. FOR STUDY BIOETHICAL ISSUES,
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twelve ways in which whole genome sequencing can be
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vulnerability to warrant exclusion from core military assignments—or,
more crucially, from military service itself—what should civilian
institutions make of that fact when assessing the merits of veteran
applicants for high stress positions? In civilian life, the prudential
over-determinism of PTSD-PGS could easily be misinterpreted as a
strong genetic essentialism, allowing all the individual’s qualities to be
eclipsed by their genomic markers in a scientifically inappropriate
overinterpretation of their significance in civilian life. Even if the
applicants’ individual genomic marker results are undisclosed, a
military record of low stress assignments, or a genomic 4F designation
could come to exacerbate the social burden that veterans already face
when they are stigmatized as “unstable” or unreliable under stress. 88
The military could join other efforts within the genomics community
to demythologize genomic information though public education, but it
would have to face the challenge that the humbler interpretations of
PTSD genomics required to counteract those invidious
misinterpretations will also cut against the rationale for conducting
PTSD-PGS for personnel assignments in the first place.
D. Research Ethics Issues

Finally, how should a PTSD-PGS program be developed and
tested? To be ethically justified, it would have to be well grounded in
the best evidence available that its candidate markers were robust
predictors of PTSD risk, that assigning high risk personnel to low
stress roles would reduce that risk, and that the psychosocial sequelae
of being labeled at high PTSD risk—both during active duty and
after
discharge—do not
outweigh
its
benefits. 89
Unlike
pharmacogenomic trials involving clear physiological pathways and
discrete outcomes, it is almost impossible to imagine a controlled,
scientifically rigorous study that could produce this evidence without
amounting to the widespread implementation of the program and its
longitudinal follow-up. Biomedical research with service personnel is
sometimes excused from the usual requirements of voluntary informed
consent, free withdrawal, and confidentiality out of military necessity,
but usually in the face of some imminent threat to an overriding
military mission objective. Would the prevention of PTSD in veterans
and the accompanying health care cost savings merit such an
exemption? 90 If not, the program’s (large) exploratory phase would
88.

Dinesh Mittal et al., Stigma Associated with PTSD: Perceptions of
Treatment-Seeking Combat Veterans, 36 PSYCHIATRIC REHAB. J. 86, 88,
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have to be accompanied, like other military health services research,
with a version of the usual protections for human research
participants in place. 91 That would, again, bring the military back to
many of the same ethical challenges that genomic sequencing research
is currently facing in other clinical and public health settings.

VI. Conclusions
Despite current scientific enthusiasm over preventive genomic
sequencing, the deference of American law to military necessity, and
the unique features of military morality, the prospect of a military
PTSD-PGS program may be more challenging than the JASON
Report suggests. In fact, the three sections of this tour of the
scientific, legal and ethical considerations involved in mounting such a
program come together to effectively dissolve the rationales that
might have insulated a military program from the complexities of the
ongoing debates over PGS in our individualistic civilian context, in
four ways.
First, it is clear that the state of PTSD genomics is far from being
robust enough to support a meaningful PGS program. Under that
scientific uncertainty, commanders will not have the evidence they
need to make responsible decisions about their subordinates’ best
interests in this context, given the possible harms of PTSD risk
labeling in both active duty and post-discharge settings. Since it is
unlikely that any individual’s downstream risks for PTSD will
jeopardize a unit’s immediate functionality except through the
destabilizing effects of reassignment, commanders who are given a
choice are likely to forego the program for those under their
command, despite the risk of increased costs to the military health
care system. If commanders are not given a choice but are unable to
endorse the program, military ethics prescribes that they share their
inability with their troops and relinquish their paternalistic authority
by calling for volunteers.
Second, while legal doctrine might support the military’s
authority to create a PTSD-PGS program, such a program’s
interfaces with the civilian lives of either new recruits or discharged
veterans reintroduce legal and civil rights challenges that strictly
internal military interventions can avoid. If PTSD-PGS is used as a
recruiting screen, it faces both constitutional challenges and the
ethical complexities of civilian genomic sequencing. If it is limited to
that the military regulations regarding informed consent exist solely to
protect military members on the battlefield, and that the current rules
preclude genuine experimentation, as had occurred with LSD).
91.
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active duty personnel, its planners must develop ways to mitigate the
potentially adverse impact of PTSD risk labeling on veterans
opportunities and the lives of their families.
Third, the practice of segregating personnel with high genomic
PTSD risk into low stress assignments may run afoul of the military’s
own ethical commitment to a level playing field for meritocratic
advancement, and its disinterest in stigmatizing critical non-combat
vocations. As a result, even the military’s internal morality may push
planners to make room for informed choices by volunteers who are
willing, like the ship’s cook manning the anti-aircraft gun at Pearl
Harbor, to take on additional PTSD risks in their unit’s interest.
Fourth, since PTSD-PGS does not address any imminent military
necessity beyond the long-term health and health care costs of
individual personnel, its development should be governed by the
research ethics that regulates other health service research in the
military. If PTSD-PGS is to eventually gain the evidence base it will
require to be ethically justifiable as a universal military program, it
will require testing in longitudinal cohort studies that will have to
offer their participating personnel the standard autonomy-oriented
protections.
Discussions of workplace genetic screening in the 1980’s often
ended with a recommendation that represented a compromise between
those who would use genetic testing to involuntarily exclude the
hypersusceptible from occupational exposures to toxins and those who
criticized such proposals as paternalistic and potentially
discriminatory. 92 The compromise was to have companies offer the
genetic testing as a health service to their workers, and to allow
individual employees to decide whether or not to avail themselves of
the service or follow up on its findings. While some declined such
services, those that used them and discovered themselves to be
hypersusceptible to the workplace toxins overwhelmingly took
voluntary steps to minimize their risks. It may be that this is where
the challenges in PTSD-PGS in the military are pointing as well.
From the legal and ethical perspectives the least problematic way of
establishing an PTSD-PGS program for military personnel may be to
make it a voluntary program for service members and to offer
targeted sequencing of those loci that are known to be most relevant
to the phenotypes most closely associated with a given individual’s
military duties. Under this personalized approach to PTSD-PGS,
individual service members would decide whether to learn their own
risk status as a matter of personal health planning beyond their
military responsibilities rather than as a matter of professional
military duty. Those that learned they were at increased genomic risk
92.
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for PTSD could be given the opportunity to decide whether they
want to report this information in order to request reasonable
accommodation, similar to the way the American’s with Disabilities
Act works in civilian contexts. This degree of autonomy may be at
odds with military tradition. But, the probabilistic information that
PTSD-PGS will be able to provide for the foreseeable future is so
uncertain, can have such profound implications for service members’
social success within and beyond the military, and could be
misinterpreted and misused in so many ways detrimental to military
values, that repositioning PGS as an optional perk of military service,
like subsidized PX prices or the G.I. Bill, rather than using it as a
weapon, an element of a new genomic arms race, may be the better
part of valor.
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